Weekly digest: the latest news on topics important to Open Pharma

Featuring the ‘No deal, no review’ campaign to break down paywalls, research on how best to generate and communicate science, and ‘Tinder for preprints’ Finnish academics campaign against Elsevier paywalls via No deal, no review This is the newly launched website of the No deal, no review campaign, which is urging academics to  refuse to … Continue reading Weekly digest: the latest news on topics important to Open Pharma

Weekly digest: the latest news on topics important to Open Pharma

An invitation to share your thoughts on ORCID, ways to support preprints and a look at how piracy can negatively affect open-access journals Why open-access journals aren’t immune to piracy via The Scholarly Kitchen We may not know why people still use Sci-Hub to access content that is already open access, but this post sheds … Continue reading Weekly digest: the latest news on topics important to Open Pharma

Weekly digest: the latest news on topics important to Open Pharma

Including next steps for Open Pharma, the launch of the MyScienceOpen platform, an update on Horizon 2020 and a spotlight on predatory publishing Open Pharma workstream overviews via the Open Pharma blog This post reports the insights and next steps arising from discussions at the four Open Pharma kick-off meetings in May. These discussions focused … Continue reading Weekly digest: the latest news on topics important to Open Pharma